# PrEP at a Syringe Services Program

> **NCT04782180** · PHASE4 · COMPLETED · sponsor: **University of Miami** · enrollment: 90 (actual)

## Conditions studied

- Hiv
- Substance Use Disorders

## Interventions

- **DRUG:** Descovy 200Mg 25Mg Tablet
- **BEHAVIORAL:** PrEP

## Key facts

- **NCT ID:** NCT04782180
- **Lead sponsor:** University of Miami
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2022-02-01
- **Primary completion:** 2024-11-11
- **Final completion:** 2024-11-11
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2025-12-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04782180

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04782180, "PrEP at a Syringe Services Program". Retrieved via AI Analytics 2026-07-12 from https://api.ai-analytics.org/clinical/NCT04782180. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*